Epigenetic alterations and their clinical implications in esophageal squamous cell carcinoma.
about
The detective, prognostic, and predictive value of DNA methylation in human esophageal squamous cell carcinomaOverexpression of long non-coding RNA UCA1 predicts a poor prognosis in patients with esophageal squamous cell carcinomaEpigenetics in the Pathogenesis of Esophageal AdenocarcinomaExpression and role of oncogenic miRNA-224 in esophageal squamous cell carcinoma.Elevated expression of MDR1 associated with Line-1 hypomethylation in esophageal squamous cell carcinomaSpatial intratumoral heterogeneity and temporal clonal evolution in esophageal squamous cell carcinomaAberrant promoter methylation of cancer-related genes in human breast cancer.Molecular alterations and clinical relevance in esophageal squamous cell carcinoma.MicroRNAs as oncogenes or tumour suppressors in oesophageal cancer: potential biomarkers and therapeutic targets.Overexpression of zinc finger E-box binding homeobox factor 1 promotes tumor invasiveness and confers unfavorable prognosis in esophageal squamous cell carcinoma.FoxC1 promotes epithelial-mesenchymal transition through PBX1 dependent transactivation of ZEB2 in esophageal cancer.Promoter methylation of BRCA1 in the prognosis of breast cancer: a meta-analysis.Epigenetic alterations of the Igf2 promoter and the effect of miR‑483‑5p on its target gene expression in esophageal squamous cell carcinoma.MicroRNA-133b inhibits cell proliferation and promotes apoptosis by targeting cullin 4B in esophageal squamous cell carcinoma.ABC Transporters and Their Role in the Neoadjuvant Treatment of Esophageal Cancer.The novel 19q13 KRAB zinc-finger tumour suppressor ZNF382 is frequently methylated in oesophageal squamous cell carcinoma and antagonises Wnt/β-catenin signalling.
P2860
Q26750641-36ACA95D-2BBD-47E0-B3C7-1CD0BCFFE490Q34733101-D4910425-979D-47C3-859C-D7A0789AC27EQ35598456-7E5136E3-32C9-40B0-9458-92D4C6290F9FQ35738190-0AFB8F56-EDB2-4EB5-9580-853A83313C2CQ36464436-DB8933A5-928E-4D3D-99F9-9B6CD75C2B81Q37452434-DF89D14C-052F-4BEF-AB8F-3C005E4904F6Q37582122-D5377DE9-FA57-47B6-9873-9FD0A96C757EQ38134029-0EBF33E8-420A-4FD7-B7FD-98E2FDDAAEB0Q38218553-F54C8C81-38EF-4A06-AC8C-14DF085C59C0Q38964268-768143B2-C308-4F6D-B100-01E11EB76939Q41547588-951DBDA0-F194-4E8C-9090-79C2374A9699Q46950071-D9FF7440-CEC3-4E38-B2F2-027066FE4F36Q50065793-9FE9F5E0-EA19-4E00-9794-398205AB8DCAQ54981639-1068AC0C-4A96-4AD4-81D7-8CEF1E770230Q55000594-69434A75-75E4-4B7A-97A3-8A4B11DFC6FAQ55100603-C43CA43F-8F8E-495B-AB85-9187296D1555
P2860
Epigenetic alterations and their clinical implications in esophageal squamous cell carcinoma.
description
article científic
@ca
article scientifique
@fr
articol științific
@ro
articolo scientifico
@it
artigo científico
@gl
artigo científico
@pt
artigo científico
@pt-br
artikel ilmiah
@id
artikull shkencor
@sq
artículo científico
@es
name
Epigenetic alterations and the ...... ageal squamous cell carcinoma.
@en
type
label
Epigenetic alterations and the ...... ageal squamous cell carcinoma.
@en
prefLabel
Epigenetic alterations and the ...... ageal squamous cell carcinoma.
@en
P2093
P2860
P1476
Epigenetic alterations and the ...... ageal squamous cell carcinoma.
@en
P2093
Akinori Egashira
Manabu Yamamoto
Yasushi Toh
P2860
P2888
P304
P356
10.1007/S11748-013-0235-3
P577
2013-03-26T00:00:00Z